Development of fibrosis in acute and longstanding ulcerative colitis

Journal of Crohn's and Colitis

Volumn 9, Issue 11, 2015, Pages 966-972

  De Bruyn, Jessica R ^a   Meijer, Sybren L ^a   Wildenberg, Manon E ^a   Bemelman, Willem A ^a   Van Den Brink, Gijs R ^a   D'Haens, Geert R ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

fibrosis; pathology; Ulcerative colitis

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; FIBRONECTIN; INFLIXIMAB; BIOLOGICAL MARKER;

ACUTE DISEASE; ACUTE ULCERATIVE COLITIS; ADULT; ARTICLE; CANCER CONTROL; CANCER SURGERY; CHRONIC DISEASE; COLON MUCOSA; COLON RESECTION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINAL FIBROSIS; LONGSTANDING ULCERATIVE COLITIS; MAJOR CLINICAL STUDY; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBMUCOSA; ULCERATIVE COLITIS; AGED; CASE CONTROL STUDY; COLITIS, ULCERATIVE; COLON; COLON TUMOR; FIBROSIS; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; SEVERITY OF ILLNESS INDEX;

ACUTE DISEASE; ADULT; AGED; BIOMARKERS; CASE-CONTROL STUDIES; CHRONIC DISEASE; COLECTOMY; COLITIS, ULCERATIVE; COLON; COLONIC NEOPLASMS; DISEASE PROGRESSION; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MIDDLE AGED; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84963767435     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jjv133     Document Type: Article

References (38)

1. Donnellan WL, Beal JM. Early pathologic changes in ulcerative colitis. Their relation to surgical complications. Am J Surg 1966;111:107-13
2. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002;8:244-50
3. De Dombal FT, Watts JM, Watkinson G, Goligher JC. Local complications of ulcerative colitis: stricture, pseudopolyposis, and carcinoma of colon and rectum. Br Med J 1966;1:1442-7
4. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. III. Complications. Gut 1964;5:1-22
5. Gumaste V, Sachar DB, Greenstein AJ. Benign and malignant colorectal strictures in ulcerative colitis. Gut 1992;33:938-41
6. Yamagata M, Mikami T, Tsuruta T, et al. Submucosal fibrosis and basicfibroblast growth factor-positive neutrophils correlate with colonic stenosis in cases of ulcerative colitis. Digestion 2011;84:12-21
7. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001;49:777-82
8. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008;214:199-210
9. Powell DW, Mifflin RC, Valentich JD, Crowe SE, Saada JI, West AB. Myofibroblasts. I. Paracrine cells important in health and disease. Am J Physiol 1999;277[1 Pt 1]:C1-C9
10. Pucilowska JB, Williams KL, Lund PK. Fibrogenesis. IV. Fibrosis and inflammatory bowel disease: cellular mediators and animal models. Am J Physiol Gastrointest Liver Physiol 2000;279:G653-9
11. Kalluri R, Neilson EG. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003;112:1776-84
12. Leeb SN, Vogl D, Grossmann J, et al. Autocrine fibronectin-induced migration of human colonic fibroblasts. Am J Gastroenterol 2004;99:335-40
13. Wegrowski J, Lafuma C, Lefaix JL, Daburon F, Robert L. Modification of collagen and noncollagenous proteins in radiation-induced muscular fibrosis. Exp Mol Pathol 1988;48:273-85
14. Lawrance IC, Maxwell L, Doe W. Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease. Inflamm Bowel Dis 2001;7:226-36
15. Xu X, Rivkind A, Pikarsky A, Pappo O, Bischoff SC, Levi-Schaffer F. Mast cells and eosinophils have a potential profibrogenic role in Crohn disease. Scand J Gastroenterol 2004;39:440-7
16. Simmons JG, Pucilowska JB, Keku TO, Lund PK. IGF-I and TGF-beta1 have distinct effects on phenotype and proliferation of intestinal fibroblasts. Am J Physiol Gastrointest Liver Physiol 2002;283:G809-18
17. Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005;54:237-41
18. Johnson LA, Luke A, Sauder K, Moons DS, Horowitz JC, Higgins PD. Intestinal fibrosis is reduced by early elimination of inflammation in a mouse model of IBD: impact of a "Top-Down" approach to intestinal fibrosis in mice. Inflamm Bowel Dis 2012;18:460-71
19. De Dombal FT, Geffen N, Darnborough A, Watkinson G, Goligher JC. Radiological appearances of ulcerative colitis: an evaluation of their clinical significance. Gut 1968;9:157-63
20. Goulston SJ, McGovern VJ. Strictures in ulcerative colitis. N Engl J Med 1969;281:800
21. Gore RM. Colonic contour changes in chronic ulcerative colitis: reappraisal of some old concepts. AJR Am J Roentgenol 1992;158:59-61
22. Hruban RH, Westra WH, Phelps TH, Isacson C. Surgical Pathology Dissection; An Illustrated Guide. New York, NY: Springer; 1996
23. Junqueira LC, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 1979;11:447-55
24. Geboes K, Riddell R, Ost A, Jensfelt B, Persson T, Lofberg R. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 2000;47:404-9
25. Vaday GG, Lider O. Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation. J Leukoc Biol 2000;67:149-59
26. Rieder F, Brenmoehl J, Leeb S, Scholmerich J, Rogler G. Wound healing and fibrosis in intestinal disease. Gut 2007;56:130-9
27. Leeb SN, Vogl D, Falk W, Scholmerich J, Rogler G, Gelbmann CM. Regulation of migration of human colonic myofibroblasts. Growth Factors 2002;20:81-91
28. Francoeur C, Bouatrouss Y, Seltana A, et al. Degeneration of the pericryptal myofibroblast sheath by proinflammatory cytokines in inflammatory bowel diseases. Gastroenterology 2009;136:268-77
29. Otte JM, Rosenberg IM, Podolsky DK. Intestinal myofibroblasts in innate immune responses of the intestine. Gastroenterology 2003;124:1866-78
30. Powell DW, Adegboyega PA, Di Mari JF, Mifflin RC. Epithelial cells and their neighbors I. Role of intestinal myofibroblasts in development, repair, and cancer. Am J Physiol Gastrointest Liver Physiol 2005;289:G2-G7
31. Kruidenier L, MacDonald TT, Collins JE, Pender SL, Sanderson IR. Myofibroblast matrix metalloproteinases activate the neutrophil chemoattractant CXCL7 from intestinal epithelial cells. Gastroenterology 2006;130:127-36
32. Beaulieu JF. Extracellular matrix components and integrins in relationship to human intestinal epithelial cell differentiation. Prog Histochem Cytochem 1997;31:1-78
33. Lawrance IC, Maxwell LF, Doe W. Inflammation location, but not type, determines the increase in TGF-beta1 and IGF-1 expression and collagen deposition in IBD intestine. Inflamm Bowel Dis 2001;7:16-26
34. Manetti M, Rosa IF, Messerini LF, Ibba-Manneschi L. Telocytes are reduced during fibrotic remodelling of the colonic wall in ulcerative colitis. J Cell Mol Med 2015;19:62-73
35. Sponheim J, Pollheimer JF, Olsen TF, et al. Inflammatory bowel diseaseassociated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. Am J Pathol 2010;177:2804-15
36. Kern F Jr, Almy TP, Abbot FK, Bogdonoff MD. The motility of the distal colon in nonspecific ulcerative colitis. Gastroenterology 1951;19:492-503
37. Spriggs EA, Code CF, Bargen JA, Curtiss RK, Hightower NC Jr. Motility of the pelvic colon and rectum of normal persons and patients with ulcerative colitis. Gastroenterology 1951;19:480-91
38. Bernardini N, Segnani C, Ippolito C, et al. Immunohistochemical analysis of myenteric ganglia and interstitial cells of Cajal in ulcerative colitis. J Cell Mol Med 2012;16:318-27